Diligence memo · auto-generated · as of July 2, 2026

OncoHoldings, Inc.

OncoHoldings, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

OncoHoldings, Inc. operates in Pharmaceuticals, based in SYRACUSE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

OncoHoldings, Inc. has raised $183K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $183K on 2010-10-15.

Most recent recorded round closed around 2010-10-15.

Valuation (modeled)modeled

Provath models OncoHoldings, Inc. at approximately $8.6M (range $102K–$98M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.46× the median modeled value of Pre-Seed Pharmaceuticals companies in 2010–2012 (71 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 15.7 yr ago; this sector typically re-raises about every 13 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 4% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 15% of those peers.

Closest niche peers: Dermal Life, LLC, Armgo Pharma Inc, Third Day Healing Holdings LLC, Dermamedics Llc, China Yongxin Pharmaceuticals Inc..

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.